To evaluate the impact of GPRIN2 and FDX1 on the tumorigenic potential of LUAD cells in vivo, we established a subcutaneous transplantation tumor model using FDX1-overexpressing A549 cells with or without GPRIN2 knockdown in nude mice. Here, GPRIN2 is linked to neoplasm.